Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Handa Pharmaceuticals Inc (6620) Financial Statements

Handa Pharmaceuticals Inc Financial Overview

Handa Pharmaceuticals Inc's market cap is currently NT$20.83B. The company's EPS TTM is NT$3.08; its P/E ratio is 72.70; and it has a dividend yield of 1.65%. Handa Pharmaceuticals Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.73BNT$ 830.67MNT$ 1.11BNT$ 197.68MNT$ 29.23M
Gross ProfitNT$ 1.46BNT$ 829.50MNT$ 1.11BNT$ 178.97MNT$ 27.77M
Operating IncomeNT$ 934.18MNT$ 418.06MNT$ 693.43MNT$ -88.12MNT$ -253.88M
EBITDANT$ 1.10BNT$ 490.09MNT$ 802.78MNT$ -27.69MNT$ -225.41M
Net IncomeNT$ 749.77MNT$ 472.74MNT$ 726.89MNT$ -40.01MNT$ -247.67M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 3.71BNT$ 1.83BNT$ 2.32BNT$ 368.50MNT$ 296.61M
Total AssetsNT$ 5.89BNT$ 3.44BNT$ 3.04BNT$ 790.56MNT$ 498.53M
Total DebtNT$ 47.64MNT$ 40.10MNT$ 13.24MNT$ 29.59MNT$ 11.89M
Net DebtNT$ -1.76BNT$ -557.28MNT$ -653.81MNT$ -336.32MNT$ -251.41M
Total LiabilitiesNT$ 232.05MNT$ 324.09MNT$ 280.88MNT$ 69.44MNT$ 35.42M
Stockholders' EquityNT$ 5.66BNT$ 3.12BNT$ 2.76BNT$ 721.12MNT$ 463.10M
Cash Flow
Free Cash FlowNT$ 226.55MNT$ 489.83MNT$ 667.42MNT$ -212.33MNT$ -186.39M
Operating Cash FlowNT$ 243.63MNT$ 497.60MNT$ 668.36MNT$ -211.57MNT$ -179.24M
Investing Cash FlowNT$ -847.84MNT$ -396.92MNT$ -1.66BNT$ 29.50MNT$ -2.91M
Financing Cash FlowNT$ 1.79BNT$ -200.55MNT$ 1.31BNT$ 313.64MNT$ 162.91M

Currency in TWD

Handa Pharmaceuticals Inc Earnings and Revenue History

-1B01B2B-1200 %-600 %0 %600 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Handa Pharmaceuticals Inc Liabilities to Assets

02.5B5B7.5B2.5 %5 %7.5 %10 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Handa Pharmaceuticals Inc Cash Flow

-2B-1B01B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Handa Pharmaceuticals Inc Forecast EPS vs Actual EPS

-10123Q2 25Q3 25Q4 25Q1 26Q3 26EPS EstimateBeatMiss
Earnings >